UPDATED Mar 28, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$420.72 | -2.0% | 48.1% | US$3.1t | US$468.20 | PE37.9x | E12.6% | 0.7% | Software | ||
AAPL | US$171.48 | -0.5% | 4.0% | US$2.6t | US$200.53 | PE26.2x | E4.8% | 0.6% | Tech | ||
GOOGL | US$150.93 | 0.1% | 45.5% | US$1.9t | US$164.92 | PE25.4x | E11.8% | n/a | Media | ||
AMZN | US$180.38 | 1.3% | 76.8% | US$1.9t | US$206.32 | PE61.6x | E22.0% | n/a | Retail | ||
META | US$485.58 | -4.7% | 129.1% | US$1.2t | US$524.03 | PE31.7x | E14.3% | 0.4% | Media | ||
LLY | US$777.96 | 1.0% | 128.3% | US$701.0b | US$797.44 | PE133.7x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
AVGO | US$1,325.41 | -1.7% | 109.1% | US$611.1b | US$1,497.90 | PE53x | E23.4% | 1.6% | Semiconductors | ||
JPM | US$200.30 | 0.6% | 55.6% | US$574.7b | US$198.38 | PB1.9x | E-1.4% | 2.3% | Banks | ||
WMT | US$60.17 | -2.1% | 23.9% | US$489.3b | US$65.13 | PE31.3x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$116.24 | 2.4% | 6.2% | US$456.2b | US$124.67 | PE12.8x | E-1.5% | 3.3% | Energy | ||
UNH | US$494.70 | 0.6% | 5.2% | US$454.6b | US$589.45 | PE20.4x | E9.6% | 1.5% | Healthcare | ||
A005930 | ₩82,400.00 | 4.4% | 28.7% | ₩537.7t | ₩95,908.33 | PE38.7x | E27.4% | 1.8% | Tech | ||
PG | US$162.25 | 0.2% | 10.0% | US$382.6b | US$169.11 | PE26.4x | E7.3% | 2.3% | Household | ||
JNJ | US$158.19 | 1.6% | 3.1% | US$380.6b | US$175.41 | PE28.6x | E9.5% | 3.0% | Pharmaceuticals & Biotech | ||
700 | HK$303.80 | 5.2% | -21.3% | HK$2.8t | HK$421.60 | PE22.7x | E15.1% | 1.1% | Media | ||
ORCL | US$125.61 | -2.6% | 38.8% | US$344.3b | US$137.02 | PE32.4x | E14.9% | 1.3% | Software | ||
MRK | US$131.95 | 6.7% | 24.6% | US$333.7b | US$136.21 | PE915.6x | E25.3% | 2.3% | Pharmaceuticals & Biotech | ||
COST | US$732.63 | -1.3% | 49.1% | US$324.7b | US$758.77 | PE47.8x | E7.4% | 0.6% | Consumer Retailing | ||
ABBV | US$182.10 | 2.6% | 15.3% | US$319.3b | US$183.88 | PE66.9x | E23.1% | 3.4% | Pharmaceuticals & Biotech | ||
BAC | US$37.92 | 1.1% | 34.0% | US$298.3b | US$37.77 | PB1.1x | E3.6% | 2.5% | Banks | ||
600519 | CN¥1,702.90 | 0.09% | -6.4% | CN¥2.1t | CN¥2,145.55 | PE30x | E14.5% | 1.5% | Food, Beverage & Tobacco | ||
CRM | US$301.18 | -2.3% | 53.2% | US$292.3b | US$334.14 | PE70.6x | E18.7% | 0.5% | Software | ||
CVX | US$157.74 | 1.9% | -2.9% | US$290.4b | US$175.99 | PE13.7x | E1.2% | 4.1% | Energy | ||
NESN | CHF95.75 | 0.8% | -13.5% | CHF251.0b | CHF108.80 | PE22.4x | E7.0% | 3.1% | Food, Beverage & Tobacco |